In a Bioanalysis perspective article, Rasa Santockyte (Bristol Myers Squibb, NJ, USA) explored the topic of critical reagents in LBAs and hybrid LC–MS assays. We caught up with Rasa to find out the latest in the field.
Browsing: MS (LC–MS/MS, HRMS, IMS)
Since 2013 the short course teaching best practice for maintaining and troubleshooting LC–MS systems has been delivered at the ASMS conference. Ahead of the virtual ASMS 2020 Reboot, we caught up with the course instructors to see what’s new.
In the final question of our Ask the Experts feature, we find out what the experts think the future holds for the use of LC–MS in biologics bioanalysis
In this section of our Ask the Experts feature, discover the challenges experts face in when it comes to biologic quantitation by LC–MS and what solutions can be used to address them.
As part of our Ask the Experts feature, we find out the advantages of LC–MS approaches for the bioanalysis of biologics compared with other approaches.
As part of our Ask the Experts feature, we find out the range of different LC–MS approaches and techniques the experts have used for the bioanalysis of biologics.
As part of our Ask the Experts feature, we explore some of the reasons why the field of biologics has witnessed such significant growth in recent years.
Meet the experts for our new Ask the Experts feature that probes the latest perspectives and research surrounding the analysis of biologics by LC–MS.
At the virtual ASMS 2020 Reboot conference, Bruker (MA, USA) announced the first commercially available matrix-assisted laser desorption ionization-2 (MALDI-2) source, along with the innovations in Bruker’s proteomics platforms.
In this interview we caught up with Jian Guo (University of British Columbia, Vancouver, Canada) to discuss his research inspirations, current research focus and what he hopes attendees will gain from his presentation at ASMS 2020 Reboot.